Have a personal or library account? Click to login
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay Cover

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay

Paid access
|Mar 2021

Authors

A.D. Ho

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta

H. Verkerke

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta

J.W. Allen

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta

B.J. Saeedi

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

D. Boyer

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

J. Owens

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

S. Shin

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

M. Horwath

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

K. Patel

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

A. Paul

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

S.-C. Wu

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

S. Chonat

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

P. Zerra

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

C. Lough

Lifesouth Blood Donation Services, Gainesville, USA

J.D. Roback

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

A. Neish

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

C.D. Josephson

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

C.M. Arthur

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

S.R. Stowell

srstowell@bwh.harvard.edu

Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta
DOI: https://doi.org/10.21307/immunohematology-2021-007 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 33 - 43
Published on: Mar 31, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 A.D. Ho, H. Verkerke, J.W. Allen, B.J. Saeedi, D. Boyer, J. Owens, S. Shin, M. Horwath, K. Patel, A. Paul, S.-C. Wu, S. Chonat, P. Zerra, C. Lough, J.D. Roback, A. Neish, C.D. Josephson, C.M. Arthur, S.R. Stowell, published by American National Red Cross
This work is licensed under the Creative Commons License.